These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 3137798

  • 1. Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardia.
    Hoff PI, Tronstad A, Oie B, Ohm OJ.
    Am J Cardiol; 1988 Sep 15; 62(9):585-9. PubMed ID: 3137798
    [Abstract] [Full Text] [Related]

  • 2. Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate.
    Kim SS, Lal R, Ruffy R.
    Am J Cardiol; 1986 Jul 01; 58(1):80-5. PubMed ID: 3728336
    [Abstract] [Full Text] [Related]

  • 3. Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias.
    Hellestrand KJ, Nathan AW, Bexton RS, Spurrell RA, Camm AJ.
    Am J Cardiol; 1983 Mar 01; 51(5):770-6. PubMed ID: 6829436
    [Abstract] [Full Text] [Related]

  • 4. Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia.
    Musto B, D'Onofrio A, Cavallaro C, Musto A, Greco R.
    Am J Cardiol; 1988 Aug 01; 62(4):229-33. PubMed ID: 3135739
    [Abstract] [Full Text] [Related]

  • 5. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia.
    Gambhir DS, Bhargava M, Arora R, Khalilullah M.
    Indian Heart J; 1995 Aug 01; 47(3):237-43. PubMed ID: 7558090
    [Abstract] [Full Text] [Related]

  • 6. [Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia].
    Musto B, D'Onofrio A, Cavallaro C, Musto A, Della Gatta O, Marsico F.
    G Ital Cardiol; 1987 May 01; 17(5):444-9. PubMed ID: 3115857
    [Abstract] [Full Text] [Related]

  • 7. Intravenous flecainide acetate for supraventricular tachycardias.
    Hellestrand KJ.
    Am J Cardiol; 1988 Aug 25; 62(6):16D-22D. PubMed ID: 3136630
    [Abstract] [Full Text] [Related]

  • 8. Electrophysiologic effects of isoproterenol in patients with atrioventricular reentrant tachycardia treated with flecainide.
    Helmy I, Scheinman MM, Herre JM, Sharkey H, Griffin JC.
    J Am Coll Cardiol; 1990 Dec 25; 16(7):1649-55. PubMed ID: 2123908
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination].
    Purcaro A, Capestro F, Ciampani N, Fratadocchi GB, Mazzanti M, Costantini C, Molini E.
    G Ital Cardiol; 1987 Aug 25; 17(8):690-8. PubMed ID: 3121426
    [Abstract] [Full Text] [Related]

  • 10. Flecainide acetate for treatment of bypass tract mediated reentrant tachycardia.
    Zee-Cheng CS, Kim SS, Ruffy R.
    Am J Cardiol; 1988 Aug 25; 62(6):23D-28D. PubMed ID: 3136631
    [Abstract] [Full Text] [Related]

  • 11. Flecainide acetate in the treatment of supraventricular tachycardias: value of programmed electrical stimulation for long-term prognosis.
    van Wijk LM, Crijns HJ, van Gilst WH, Wesseling H, Lie KI.
    Am Heart J; 1989 Feb 25; 117(2):365-9. PubMed ID: 2492738
    [Abstract] [Full Text] [Related]

  • 12. Prospective evaluation of parenteral magnesium sulfate in the treatment of patients with reentrant AV supraventricular tachycardia.
    Sager PT, Widerhorn J, Petersen R, Leon C, Ryzen E, Rude R, Rahimtoola SH, Bhandari AK.
    Am Heart J; 1990 Feb 25; 119(2 Pt 1):308-16. PubMed ID: 2301220
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
    Hellestrand KJ.
    Am J Cardiol; 1996 Jan 25; 77(3):83A-88A. PubMed ID: 8607396
    [Abstract] [Full Text] [Related]

  • 14. Use of intracardiac recordings to determine the site of drug action in paroxysmal supraventricular tachycardia.
    Jackman WM, Friday KJ, Fitzgerald DM, Yeung-Lai-Wah JA, Lazzara R.
    Am J Cardiol; 1988 Dec 20; 62(19):8L-19L. PubMed ID: 3059792
    [Abstract] [Full Text] [Related]

  • 15. Flecainide single oral dose for management of paroxysmal supraventricular tachycardia in children and young adults.
    Musto B, Cavallaro C, Musto A, D'Onofrio A, Belli A, De Vincentis L.
    Am Heart J; 1992 Jul 20; 124(1):110-5. PubMed ID: 1615792
    [Abstract] [Full Text] [Related]

  • 16. Clinical and electrophysiologic effects of magnesium sulfate on paroxysmal supraventricular tachycardia and comparison with adenosine triphosphate.
    Viskin S, Belhassen B, Sheps D, Laniado S.
    Am J Cardiol; 1992 Oct 01; 70(9):879-85. PubMed ID: 1529941
    [Abstract] [Full Text] [Related]

  • 17. [Effects of intravenous flecainide acetate in patients with concealed atrioventricular pathway with supraventricular tachycardia].
    Song Y.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec 01; 19(6):361-3, 397. PubMed ID: 1821351
    [Abstract] [Full Text] [Related]

  • 18. [His bundle block 2:1 during paroxysmal supraventricular tachycardia involving an occult accessory atrio-His pathway].
    Finzi A, Potenza S, Guenzati G.
    G Ital Cardiol; 1990 Dec 01; 20(12):1161-7. PubMed ID: 2128068
    [Abstract] [Full Text] [Related]

  • 19. [Electrophysiologic effects of betaxolol on conduction properties of the antegrade and retrograde pathway in patients with typical atrioventricular node reentry tachycardia following intravenous and oral administration].
    Kühlkamp V, Ickrath O, Haasis R, Seipel L.
    Z Kardiol; 1988 Aug 01; 77(8):527-33. PubMed ID: 3176596
    [Abstract] [Full Text] [Related]

  • 20. Long-term efficacy and safety of flecainide for supraventricular tachycardia.
    Neuss H, Schlepper M.
    Am J Cardiol; 1988 Aug 25; 62(6):56D-61D. PubMed ID: 3136637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.